Filing Details
- Accession Number:
- 0001493152-20-023174
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-09 11:28:36
- Reporting Period:
- 2020-11-30
- Accepted Time:
- 2020-12-09 11:28:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1335105 | Lixte Biotechnology Holdings Inc. | LIXT | Pharmaceutical Preparations (2834) | 202903526 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1704044 | Tak Hung Ho | Mayfair By The Sea, Tower T8, 1/F, Unit A, 21 Fo Chun Road Taipo Nt, K3 SAR | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-11-30 | 42,105 | $4.75 | 0 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common | Warrants to Purchase Common Stock | Acquisiton | 2020-11-30 | 42,105 | $4.75 | 42,105 | $5.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
42,105 | 2020-11-30 | 2025-11-30 | No | 4 | P | Direct |
Footnotes
- The reporting person acquired 42,105 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit.